Clinical Trial Update: An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids [Phase 3]

View source ↗

Summary

An extension study evaluating the efficacy and safety of elagolix in premenopausal women with heavy menstrual bleeding due to uterine fibroids has completed Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Uterine Fibroids

Drugs mentioned

• Elagolix (elagolix)

Snippet

Sponsor: AbbVie | Conditions: Uterine Fibroids, Heavy Menstrual Bleeding | Phase 3 | Status: COMPLETED | Results posted: 2020-06-30